P

Inventor

AHMAD SALEEM

US60 patents
⚠️ This page may combine multiple inventors who share the name “AHMAD SALEEM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

45 patents
US6916813B2Jul 12, 2005

(1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase

BRISTOL MYERS SQUIBB CO80 citations96
US6887870B1May 3, 2005

Heterocyclic sodium/proton exchange inhibitors and method

BRISTOL MYERS SQUIBB CO51 citations95
US8791091B2Jul 29, 2014

Aryl dihydropyridinone and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO18 citations92
US7745447B2Jun 29, 2010

Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists

BRISTOL MYERS SQUIBB CO28 citations92
US7326705B2Feb 5, 2008

Heterocyclic sodium/proton exchange inhibitors and method

BRISTOL MYERS SQUIBB CO24 citations92
US6664250B2Dec 16, 2003

Lactam derivatives as antiarrhythmic agents

BRISTOL MYERS SQUIBB CO30 citations92
US6624309B1Sep 23, 2003

Benzoic acid derivatives and related compounds as antiarrhythmic agents

BRISTOL MYERS SQUIBB CO33 citations92
US6262068B1Jul 17, 2001

Lactam derivatives as antiarrhythmic agents

BRISTOL MYERS SQUIBB CO49 citations92
US5314893AMay 24, 1994

Antiviral tetrahydropyrans

BRISTOL MYERS SQUIBB CO29 citations92
US9896431B2Feb 20, 2018

Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO5 citations84
US9688629B2Jun 27, 2017

Indole carboxamide compounds

BRISTOL MYERS SQUIBB CO6 citations84
US9688656B2Jun 27, 2017

Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO7 citations84
US7973159B2Jul 5, 2011

Non-basic melanin concentrating hormone receptor-1 antagonists

BRISTOL MYERS SQUIBB CO10 citations84
US7851622B2Dec 14, 2010

Non-basic melanin concentrating hormone receptor-1 antagonists

BRISTOL MYERS SQUIBB CO10 citations84
US7371759B2May 13, 2008

HMG-CoA reductase inhibitors and method

BRISTOL MYERS SQUIBB CO11 citations84
US6048877AApr 11, 2000

Tetralone derivatives as antiarrhythmic agents

BRISTOL MYERS SQUIBB CO16 citations84
US9901572B2Feb 27, 2018

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO6 citations83
US9663466B2May 30, 2017

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO8 citations83
US9187424B1Nov 17, 2015

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO10 citations83
US8012984B2Sep 6, 2011

Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods

BRISTOL MYERS SQUIBB CO7 citations83
US7618980B2Nov 17, 2009

Pyrrolo(oxo)quinolines as 5HT ligands

BRISTOL MYERS SQUIBB CO11 citations83
US7572805B2Aug 11, 2009

Pyrrolo(oxo)isoquinolines as 5HT ligands

BRISTOL MYERS SQUIBB CO12 citations83
US9365558B2Jun 14, 2016

Dihydropyridinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO9 citations82
US6011059AJan 4, 2000

Acyl guanidine sodium/proton exchange inhibitors and method

BRISTOL MYERS SQUIBB CO14 citations74
US5414096AMay 9, 1995

Antiviral tetrahydropyrans

BRISTOL MYERS SQUIBB CO7 citations74
US10538505B2Jan 21, 2020

Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO1 citations73
US10329273B2Jun 25, 2019

Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO1 citations73
US10093650B2Oct 9, 2018

Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO3 citations73
US10695328B2Jun 30, 2020

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO2 citations72
US10369140B2Aug 6, 2019

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO3 citations72
US6160134ADec 12, 2000

Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines

BRISTOL MYERS SQUIBB CO8 citations71
US11479538B2Oct 25, 2022

Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO0 citations63
US9920031B2Mar 20, 2018

Indole carboxamide compounds

BRISTOL MYERS SQUIBB CO1 citations63
US5414000AMay 9, 1995

Antiviral pyrinyl substituted tetrahydropyrans

BRISTOL MYERS SQUIBB CO4 citations63
US11623921B2Apr 11, 2023

Indole carboxamide compounds

BRISTOL MYERS SQUIBB CO0 citations62
US11053197B2Jul 6, 2021

Carbazole derivatives

BRISTOL MYERS SQUIBB CO0 citations62
US10966967B2Apr 6, 2021

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO0 citations62
US9802915B2Oct 31, 2017

Indole carboxamide compounds

BRISTOL MYERS SQUIBB CO1 citations62
US7238702B2Jul 3, 2007

Dihydroquinazolinones as 5HT modulators

BRISTOL MYERS SQUIBB CO3 citations62
US9499482B2Nov 22, 2016

Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists

BRISTOL MYERS SQUIBB CO2 citations57
US12304916B2May 20, 2025

Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US10604504B2Mar 31, 2020

Indole carboxamide compounds

BRISTOL MYERS SQUIBB CO0 citations52
US10329274B2Jun 25, 2019

Indole carboxamide compounds

BRISTOL MYERS SQUIBB CO0 citations52
US10023534B2Jul 17, 2018

Carbazole and tetrahydrocarbazole compounds useful as inhibitors of BTK

BRISTOL MYERS SQUIBB CO1 citations52
US12492186B2Dec 9, 2025

Bicyclic heterocyclic compounds useful as IRAK4 inhibitors

BRISTOL MYERS SQUIBB CO0 citations51

SQUIBB & SONS INC

2 patents

UNIV NEW YORK STATE RES FOUND

1 patent

STEIN PHILIP D

1 patent

DEVASTHALE PRATIK

1 patent

Showing the top 50 of 60 patents by PatentIndex Score.